← back to search

Yan Zhong

East China Normal University · CN
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Single-cell and spatial transcriptomics, Gene Regulatory Network Analysis, Radiomics and Machine Learning in Medical Imaging, and Medical Imaging Techniques and Applications.
h-index
35
citations
3,583
works
231
NIH funding
primary concept
email

Recent publications

Checkpoint blockade immunotherapy for multiple recurrences of radiation-induced maxillary sinus sarcoma: A case report
Technology and Health Care 2025cited by 0position: middledoi
scPOEM: robust co-embedding of peaks and genes revealing peak-gene regulation.
2025cited by 0position: contributordoi
Ultrasmall iron-gallic acid coordination polymer nanoparticles for scavenging ROS and suppressing inflammation in tauopathy-induced Alzheimer's disease
Biomaterials 2024cited by 22position: lastdoi
Cellular senescence imaging and senolysis monitoring in cancer therapy based on a β-galactosidase-activated aggregation-induced emission luminogen
Acta Biomaterialia 2024cited by 16position: middledoi
A New Theranostic Platform Against Gram‐Positive Bacteria Based on Near‐Infrared‐Emissive Aggregation‐Induced Emission Nanoparticles
Small 2024cited by 13position: middledoi
Controlled Noise: Evidence of epigenetic regulation of Single-Cell expression variability.
2024cited by 2position: contributordoi
Reduced-rank clustered coefficient regression for addressing multicollinearity in heterogeneous coefficient estimation.
2024cited by 0position: contributordoi
Controlled Noise: Evidence of Epigenetic Regulation of Single-Cell Expression Variability
2024cited by 0position: contributordoi
Stacking Ensemble Learning–Based [<sup>18</sup>F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma
Journal of Nuclear Medicine 2023cited by 37position: middledoi
Sparse spatially clustered coefficient model via adaptive regularization.
2023cited by 2position: contributordoi
The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts
Acta Pharmacologica Sinica 2021cited by 35position: firstdoi
scTenifoldNet: A Machine Learning Workflow for Constructing and Comparing Transcriptome-wide Gene Regulatory Networks from Single-Cell Data.
2020cited by 27position: contributordoi
Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
European Journal of Medicinal Chemistry 2019cited by 85position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hong Zhang · Kunming University of Science and Technology4 papers (2023–2024)James J. Cai · Singer (United States)4 papers (2020–2025) · 4 papers (2020–2025)Mei Tian · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2023–2024)Yongjian Yang · Mitchell Institute3 papers (2024–2025)Chentao Jin · Zhejiang University3 papers (2023–2024)Qiuyao Huang · Sun Yat-sen University2 papers (2019–2021)Yuanxiang Wang · Shihezi University2 papers (2019–2021) · 2 papers (2019–2021)Kai Zhu · Fudan University2 papers (2019–2021)Peili Cen · Zhejiang University2 papers (2024–2024)Shuo Shi · Harbin University of Science and Technology2 papers (2019–2021)Xiaolei Zhang · Guangdong Pharmaceutical University2 papers (2019–2021)Wenhao Hu · Sun Yat-sen University1 papers (2019–2019)Shuilin Zhao · Zhejiang University1 papers (2023–2023)Xuexin He · Hebei Medical University1 papers (2023–2023)Shumin Ouyang · Guangdong Pharmaceutical University1 papers (2021–2021)Xi Yang · Shanxi Medical University1 papers (2024–2024)Weihong Zhu · East China University of Science and Technology1 papers (2024–2024)Wenzhao Cao · Fudan University1 papers (2024–2024)